How to think about stacking NA-Semax Amidate
- This is Semax in a stabilised form, not a different compound. Combining the two is a duplicate.
- The modifications are reported to increase stability and duration relative to unmodified Semax, so amounts and timing from Semax protocols are not directly transferable.
- As with Semax, published research on the parent molecule is predominantly intranasal.
- No controlled trial has studied it combined with anything, and its own evidence base is thinner than unmodified Semax's.
Combinations in detail
Calm-focus pairing
NA-Semax Amidate + N-Acetyl Selank Amidate- Why it is proposed
- The amidated versions of the canonical Russian pairing — attention and neuroprotection alongside anxiolysis.
- What is reported in practice
- Reported intranasally, commonly Semax-variant earlier and Selank-variant later in the day.
- Cautions specific to this combination
- Both are modified forms whose specific evidence is thinner than their parent molecules'. Do not also add the unmodified parents.
Cognition + neuroprotection
NA-Semax Amidate + Epithalon- Why it is proposed
- Reported in longevity and neuroprotection discussion, combining BDNF-oriented signaling with the Khavinson pineal bioregulator.
- What is reported in practice
- Reported alongside Epithalon's short-course convention.
- Cautions specific to this combination
- Epithalon's evidence is concentrated in one research tradition with no controlled human trials on its headline claim. Thematic pairing.
Sleep counterbalance
NA-Semax Amidate (daytime) + DSIP (night)- Why it is proposed
- Reported to offset the alerting framing of the Semax variant with a sleep-oriented peptide.
- What is reported in practice
- Daytime and night-time separation.
- Cautions specific to this combination
- DSIP's evidence base is very thin; this is a scheduling rationale.
What to avoid, and why
- Adding unmodified Semax — same molecule, different stability.
- Transferring Semax amounts directly; the modifications change duration.
- Assuming injection matches the research base, which is predominantly intranasal.
- This compound's evidence base is concentrated in Russian-language literature from a small number of research groups, with limited independent Western replication, and the published research is predominantly intranasal rather than injected. Both facts should temper how confidently any stack built on it is read.
Related reading
Every combination described here is reported practice or mechanism-level reasoning. No controlled trial has studied any of these combinations, and nothing on this page is a personal protocol, a dose recommendation, or medical advice.